Picture: BLOOMBERG/WALDO SWIEGERS
Loading ...

Aspen’s disposal of its European thrombosis business has helped the firm to slash its annual net debt by more than 50%.

The debt reduction has allowed the pharmaceutical manufacturer to reinstate dividends at R2.62 after scrapping payouts before the pandemic.

Alishia Seckam spoke to CEO Stephen Saad for more detail.

The video could not be loaded.

Loading ...
Loading ...
Loading ...
View Comments